Metabolic Research

Tirzepatide is a dual-action metabolic peptide best known for supporting appetite control, weight management, blood sugar regulation, and overall metabolic health. It works by activating both GIP and GLP-1 receptors, helping reduce hunger, increase feelings of fullness, slow digestion, and improve the way the body manages glucose and energy.

Tirzepatide is the active ingredient used in the prescription medications Mounjaro and Zepbound. Mounjaro is marketed primarily for type 2 diabetes, while Zepbound is marketed for chronic weight management and certain other approved uses.

With its strong focus on appetite suppression, reduced food cravings, improved metabolic function, and long-term weight management, tirzepatide has become one of the most well-known compounds in modern weight-loss and metabolic research.